Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Grzegorz Huszcza
Institution:
Instytut Farmaceutyczny
Observed institutions:
Celon Pharma (Poland),
Instytut Farmaceutyczny
ORCID:
0009-0003-0011-5617
Observed ORCID:
0009-0003-0011-5617
OpenAlex ID:
A5081281671
Hierarchical silica monolithic tablets as novel carriers for drug delivery
2019
·
Wojciech Pudło
, Przemysław Borys
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
11
Formulation development and scale-up of dutasteride liquisolid tablets
2025
·
Krzysztof Woyna-Orlewicz
, Grzegorz Huszcza
, et al.
·
Drug Development and Industrial Pharmacy
·
3
Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
2026
·
Adriana Rakowska
, Małgorzata Dutkiewicz
, et al.
·
Pharmacological Reports
PDF
Relative Bioavailability of Ticagrelor from Hard Capsules and Film-Coated Tablets in Healthy Caucasian Volunteers
2025
·
Michal Kaza
, Agnieszka Gierczak-Pachulska
, et al.
·
Acta Poloniae Pharmaceutica - Drug Research
PDF
Bioequivalence of Rivaroxaban Hard Capsules vs. Film-Coated Tablets in Healthy White Volunteers
2024
·
Agnieszka Gierczak-Pachulska
, Michał Kaza
, et al.
·
Acta Poloniae Pharmaceutica - Drug Research
PDF
Show more works
View as search
Works count:
5
Citation count:
14
H-index:
2
I10-index:
1
Year
Topic
Type
